I
CYTK icon

InceptionR’s Cytokinetics CYTK Stock Holding History

InceptionR’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
17,151
+1,177
+7% +$84.5K 0.36% 48
2026
Q1 		$1.05M Buy
+15,974
New +$1.02M 0.25% 116
2025
Q4 		– Sell
-3,719
Closed -$204K – 660
2025
Q3 		$204K Buy
+3,719
New +$153K 0.05% 600
2025
Q2 		– Sell
-9,433
Closed -$379K – 691
2025
Q1 		$379K Buy
+9,433
New +$434K 0.11% 334
2024
Q2 		– Sell
-5,246
Closed -$368K – 644
2024
Q1 		$368K Buy
5,246
+1,782
+51% +$138K 0.09% 369
2023
Q4 		$289K Buy
+3,464
New +$125K 0.21% 233

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's CYTK Position: Q2 2026 in Review

InceptionR increased its Cytokinetics (CYTK) stake by 7.4% in Q2 2026, buying an estimated $84.5K and bringing the position to 17,151 shares worth $1.46M. The position accounts for 0.36% of the portfolio, ranked #48.

InceptionR first reported a position in CYTK in Q4 2023 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • InceptionR held 17,151 shares of Cytokinetics worth $1.46M as of Q2 2026.
  • InceptionR bought 1,177 Cytokinetics shares in Q2 2026, an estimated $84.5K.
  • Cytokinetics made up 0.36% of InceptionR's portfolio in Q2 2026, its #48 holding.
  • InceptionR first reported a position in Cytokinetics in Q4 2023 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.